| __timestamp | Catalyst Pharmaceuticals, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 21263000 |
| Thursday, January 1, 2015 | 11801342 | 18890000 |
| Friday, January 1, 2016 | 11369941 | 15295000 |
| Sunday, January 1, 2017 | 11375237 | 12944000 |
| Monday, January 1, 2018 | 19919204 | 13599000 |
| Tuesday, January 1, 2019 | 18842752 | 30391000 |
| Wednesday, January 1, 2020 | 16496715 | 13020000 |
| Friday, January 1, 2021 | 16936000 | 16287000 |
| Saturday, January 1, 2022 | 19789000 | 19943000 |
| Sunday, January 1, 2023 | 93150000 | 21042000 |
Unleashing insights
In the competitive landscape of biotechnology, innovation is the lifeblood of success. Over the past decade, Vericel Corporation and Catalyst Pharmaceuticals, Inc. have been at the forefront of this race, each investing significantly in research and development (R&D). From 2014 to 2023, Catalyst Pharmaceuticals saw a staggering 820% increase in R&D expenses, peaking in 2023 with an investment of over $93 million. In contrast, Vericel Corporation's R&D spending remained relatively stable, with a notable peak in 2019, investing approximately $30 million. This strategic focus on innovation underscores Catalyst's aggressive push towards groundbreaking therapies, while Vericel maintains a steady course. As these companies continue to innovate, their R&D investments will likely shape the future of medical advancements, offering hope to patients worldwide.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Vericel Corporation vs MannKind Corporation
Analyzing R&D Budgets: Vericel Corporation vs Wave Life Sciences Ltd.
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.
Research and Development: Comparing Key Metrics for Catalyst Pharmaceuticals, Inc. and Evotec SE